<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-biomolecules-11-00350">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Del Monte-Millán</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>García-Palomero</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Valenzuela</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Usán</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>de Austria</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Muñoz-Ruiz</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rubio</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Dorronsoro</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Martínez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Medina</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Dual binding site acetylcholinesterase inhibitors: Potential new disease-modifying agents for AD</article-title>
  <source>J Mol. Neurosci.</source>
  <year>2006</year>
  <volume>30</volume>
  <fpage>85</fpage>
  <lpage>88</lpage>
  <pub-id pub-id-type="doi">10.1385/JMN:30:1:85</pub-id>
  <pub-id pub-id-type="pmid">17192640</pub-id>
 </element-citation>
</ref>
